Literature DB >> 9731489

Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.

P J Snijders1, M van Duin, J M Walboomers, R D Steenbergen, E K Risse, T J Helmerhorst, R H Verheijen, C J Meijer.   

Abstract

In this study, we investigated telomerase activity and human telomerase reverse transcriptase (hTERT) mRNA expression in relation to high-risk human papillomavirus (HPV) DNA presence in the spectrum of cervical premalignant lesions. Reconstruction experiments revealed that telomerase activity determined by the telomeric repeat amplification protocol assay and hTERT mRNA by reverse transcriptase-PCR could be detected in down to 100 and 1 SiHa cervical cancer cells, respectively. Telomeric repeat amplification protocol analysis on cervical tissue specimens revealed that none of the histomorphologically normal cervical samples (n = 8) and cervical intraepithelial neoplasia (CIN) grade I (n = 10) and grade II (n = 8) lesions had detectable telomerase activity. However, telomerase activity was shown in 40% of CIN grade III lesions (n = 15) and 96% of squamous cell carcinomas (n = 24). Despite the fact that hTERT mRNA was found at much higher frequencies, semiquantitative reverse transcriptase-PCR revealed that elevated hTERT mRNA levels were strongly correlated with detectable telomerase activity. Furthermore, telomerase activity and elevated hTERT mRNA levels were only detected in cases that contained high-risk HPV DNA. In contrast, low or undetectable hTERT mRNA levels were demonstrated in both high-risk HPV positive and negative cases. These data indicate that telomerase activity detectable with the assay used and concomitant elevated levels of hTERT mRNA reflect a rather late step in the CIN to squamous cell carcinoma sequence, which follows infection with high-risk HPV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731489

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

Review 1.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

2.  Telomerase as a potential marker for early diagnosing cervical carcinoma.

Authors:  D A Skvortsov; N M Gasparian; M P Rubtsova; M E Zvereva; M D Fedorova; L S Pavlova; A A Bogdanov; O A Dontsova; F L Kisseljov
Journal:  Dokl Biochem Biophys       Date:  2006 May-Jun       Impact factor: 0.788

3.  Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.

Authors:  P L Cheah; L M Looi; M H Ng; V Sivanesaratnam
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

4.  Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Authors:  Malin Lando; Christina S Fjeldbo; Saskia M Wilting; Barbara C Snoek; Eva-Katrine Aarnes; Malin F Forsberg; Gunnar B Kristensen; Renske Dm Steenbergen; Heidi Lyng
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

5.  NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.

Authors:  Portia A Vliet-Gregg; Kristin L Robinson; Justine Levan; Lisa R Matsumoto; Rachel A Katzenellenbogen
Journal:  Cancer Lett       Date:  2019-02-16       Impact factor: 8.679

6.  The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.

Authors:  S Song; H C Pitot; P F Lambert
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 7.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

8.  hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.

Authors:  Jillian de Wilde; Jan M Kooter; Renée M Overmeer; Debbie Claassen-Kramer; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

9.  Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.

Authors:  N Reesink-Peters; M N Helder; G B A Wisman; A J Knol; S Koopmans; H M Boezen; E Schuuring; H Hollema; E G E de Vries; S de Jong; A G J van der Zee
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

10.  Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis.

Authors:  Renske D M Steenbergen; Vanessa E OudeEngberink; Debbie Kramer; Henri F J Schrijnemakers; Rene H M Verheijen; Chris J L M Meijer; Peter J F Snijders
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.